微量金属元素含量与高胆固醇致病关系的研究

1 对象与方法 1.1 观察对象 住院冠心病人44例,男女各22名,年龄45～77岁,平均62.1岁.临床诊断标准符合WHO标准 ,即典型心绞痛,伴心电图ST段水平下移≥0.05mV,T波倒置.对照组42例,选择经体检,心电图、B超、血脂、血糖、肝、肾功能等各项检查,排除了与心脑血管有关的疾病的健康人 ,并在年龄、性别方面作了适当匹配.     

慢性肾衰肾虚证患者血清微量元素的变化及其临床意义探讨

讨论了慢性肾衰肾阳虚和肾阴虚见证者血清微量元素。结果显示：肾阳虚患者血清Ｃｕ、Ｃｕ／Ｚｎ明显高于健康对照组,而血清Ｚｎ和Ｆｅ低于对照组,肾阳虚患者血清Ｃｕ、Ｃｕ／Ｚｎ也明显高于肾阴虚组,而血清Ｚｎ是低的,在肾阴虚组与对照组之间Ｃｕ、Ｚｎ、Ｃｕ／Ｚｎ均无明显差异。     

复方心可舒治疗冠心病多靶点作用的分子对接

心可舒为治疗冠心病的常用中药复方,临床疗效确切,但是其效应物质基础和作用机制一直没有得到明确的解释.本文以从心可舒中直接鉴定出的51个化学成分和过氧化物酶体增生物激活受体γ(PPAR-γ),血管紧张素I转化酶(ACE),羟甲基戊二酰辅酶A还原酶(HMGR),环氧合酶2(COX-2)以及凝血酶(thrombin)等5个冠心病相关靶点为研究对象,采用LibDock和AutoDock2种分子对接程序联合对接的方法对以上化学成分和靶点的相互作用进行探讨.首先用均方根偏差(RMSD)和富集因子(EF)考察了2种程序对于5个靶点受体配体结合体系的适用性,进而发现当2种程序联合使用时,各靶点的富集因子较程序单独使用时有明显的提高,因而最终使用LibDock和AutoDock联合进行筛选.计算结果表明心可舒中的葛根苷A、葛根苷B、丹酚酸A和丹酚酸C4个化合物可能作用于2个或者2个以上的靶点,另外还有8个化合物能够分别作用于5个靶点的其中1个靶点.本研究初步阐释了心可舒多靶点作用的分子机制,为心可舒的后期开发提供了一定的参考.     

肾炎及肾衰患者血中金属元素含量的变化

用原子吸收法或极谱法测定了对例慢性肾炎病人（A组）和24例慢性肾衰病人(B组)及40名健康人（对照组，C组）全血中的Fe、Zn、Cu、Mn、Se、Pb和Ga含量。结果表明，A组与C组比较．血中Fe的含量A组明显低于C组（P＜0.05），Zn、Mn和Se的含量A组均非常明显低于C组（P＜0.01），Pb含量A组非常明显高于C组（P＜0．01），Cu和Ca含量两组间均无明显差异（P＞0.05）；B组与C组比较，Fe含量B组明显低于C组（P＜0.06），Se含量则B组明显高于C组（P＜0.05）；Zn、Mn、Cu、Ga含量B组均非常明显低于C组（P＜0.01），而Pb含量则B组非常明显高于C组（P＜0．01）。     

Heart Regeneration: Opportunities and Challenges for Drug Discovery with Novel Chemical and Therapeutic Methods or Agents

Following a heart attack, more than a billion cardiac muscle cells (cardiomyocytes) can be killed, leading to heart failure and sudden death. Much research in this area is now focused on the regeneration of heart tissue through differentiation of stem cells, proliferation of existing cardiomyocytes and cardiac progenitor cells, and reprogramming of fibroblasts into cardiomyocytes. Different chemical modalities (i.e. methods or agents), ranging from small molecules and RNA approaches (including both microRNA and anti‐microRNA) to modified peptides and proteins, are showing potential to meet this medical need. In this Review, we outline the recent advances in these areas and describe both the modality and progress, including novel screening strategies to identify hits, and the upcoming challenges and opportunities to develop these hits into pharmaceuticals, at which chemistry plays a key role.     

Determination of 12 potential nephrotoxicity biomarkers in rat serum and urine by liquid chromatography with mass spectrometry and its application to renal failure induced by Semen Strychni

In previous nephrotoxicity metabonomic studies, several potential biomarkers were found and evaluated. To investigate the relationship between the nephrotoxicity biomarkers and the therapeutic role of Radix Glycyrrhizae extract on Semen Strychni‐induced renal failure, 12 typical biomarkers are selected and a simple LC–MS method has been developed and validated. Citric acid, guanidinosuccinic acid, taurine, guanidinoacetic acid, uric acid, creatinine, hippuric acid, xanthurenic acid, kynurenic acid, 3‐indoxyl sulfate, indole‐3‐acetic acid, and phenaceturic acid were separated by a Phenomenex Luna C₁₈ column and a methanol/water (5 mM ammonium acetate) gradient program with a runtime of 20 min. The prepared calibration curves showed good linearity with regression coefficients all above 0.9913. The absolute recoveries of analytes from serum and urine were all more than 70.4%. With the developed method, analytes were successfully determined in serum and urine samples within 52 days. Results showed that guanidinosuccinic acid, guanidinoacetic acid, 3‐indoxyl sulfate, and indole‐3‐acetic acid (only in urine) were more sensitive than the conventional renal function markers in evaluating the therapeutic role of Radix Glycyrrhizae extract on Semen Strychni‐induced renal failure. The method could be further used in predicting and monitoring renal failure cause by other reasons in the following researches.     

心衰标志物可视化联合检测方法研究

基于夹心免疫原理和表面免疫吸附模型,采用Image Pro Plus软件对硅片表面磁颗粒分布图像进行定量化处理,建立了硅片表面心衰标志物可视化联合检测方法。研究表明,该方法从抗体包被到获得检测结果不超过1 ｈ,操作简单,在单张硅片上可实现心衰标志物NT-proBNP和cTnI的联合检测。NT-proBNP和cTnI的最低检出限分别为21.8 pg/mL和0.034 ng/mL,检测范围分别为21.8~40000 pg/mL和0.034~50 ng/mL。83例不同程度心血管疾病患者的血清样本的检测结果与商品化免疫分析仪检测结果一致,相关系数r>0.98。因此,该快速免疫检测方法可以满足临床检测心衰标志物的需要。     

冠心病患者血脂分析与HCY测定的临床应用

目的通过研究并分析出冠心病患者的血脂组成成分,然后通过使用HCY测定的方法测定冠心病患者血清中的同型半胱氨酸含量的实际临床应用。方法 50例患有冠心病的患者和50名健康人员的血清成分中同型半胱氨酸含量,其中治疗组有25例无心肌梗塞的冠心病患者,其余25例研究对象均为有心肌梗塞患者,然后对治疗组患者的血脂组成成分进行测定并分析比较出异常成分。结果通过研究后发现治疗组的研究对象血清中的同型半胱氨酸含量远多于对照组的50例健康人员血清中的同型半胱氨酸含量,其中25例治疗组心肌梗塞患者的同型半胱氨酸含量多于25例治疗组的无心肌梗塞患者的同型半胱氨酸含量,具有统计学意义。冠心病患者的血脂组成成分Apo B100的值增加,冠心病患者的Apo A1的值和Apo A1与Apo B100的比值均减小,经统计学分析得出,具有统计学意义。结论血清同型半胱氨酸的含量改变,以及血脂中Apo B100的值和Apo A1的值与Apo B100的比值发生改变对治疗诊断与预防冠心病都有十分重要的价值。     

Isolation and Purification of Polysaccharides from Cordyceps minlitaris and Its Inhibition on the Proliferation of Rat Glomerular Mesangial Cells

The crude polysaccharide was obtained by means of the decolorization of porphyrized Cordyceps minlitaris stroma with organic solvent, extraction with hot water, precipitation in 80% ethanol, and protein removal with the Sevag method. After purification with Sephadex G-75, two of its components, CMP-1 and CMP-2, were obtained. Through the assay of gel chromatography and polarimetry, CMP-1 was identified as pure polysaccharide. The results demonstrated that CMP-1 had favorable oxidation resistance activity, which could scavenge not only oxygen-free radicals in the self-oxidation system of pyrogallic acid, but also the hydroxide-free radicals in the Fenton system. The study focused on the effects of low, medium, and high dosages of CMP-1 in rat blood serum on the proliferation of glomerular mesangial cells in vitro. Through MTT Colorimetric analysis, the activities were compared among the blank control group and the Niaoduqing positive control group CMP-1 and CMP-2. The results shows that CMP-1 was able to inhibit the proliferation of rat glomerular mesangial cells effectively. Therefore, CMP-1, one component of polysaccharides of Cordyceps minlitaris, was certainly a potential remedy for hyperplastic glomerular nephritis, whose antioxidant activity could slow down the process of chronic renal failure（CRF） to some extent.